Shusen Wang, People's Republic of China

Director
Cell Therapy
Tianjin First Central Hospital

Member of the Expert Committee of the China Organ Donation Administrative Center,Deputy Head of the Organ Regeneration and Engineering Group of the Organ Transplantation Branch of the Chinese Medical Association,Standing Committee Member of the Transplantation Technology Branch of the China Medicinal Biotechnology Association. Led the team to complete clinical innovations such as the world's first islet transplantation derived from chemically reprogrammed induced pluripotent stem cells (iPSCs), the world's first islet transplantation after pediatric liver transplantation. Took the lead in formulating the "Clinical Technical Operation Specifications for Islet Transplantation", the "Technical Operation Specifications for Clinical Islet Preparation in China", and the "Human Islet Standards". 


Lectures by Shusen Wang


© 2025 CTRMS 2025